跳至主要内容
临床试验/NCT01535196
NCT01535196终止3 期

Effects of 25-OH-D3 Vitamin Substitution in Congestive Heart Failure. Controlled, Randomized, Double Blind Trial

Semmelweis University2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2012年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
8
试验地点
2
主要终点
Survival rate

研究概览

简要总结

The investigators hypothesized that in vitamin D deficiency the 25-OH-D3 vitamin substitution improve the heart function in chronic heart failure.

Type of study: Controlled, randomized, double blind, placebo control

Number of patient: 300; 150 treated and 150 placebo controlled

Type of drug: 180 000 IU 25-OH-D3 vitamin oil (Vigantol) per month in the 0,1,2,3,6, month

Duration of study:1+1 year

Primary end points:

Survival rate, Ejection fraction by ultrasound, Brain natriuretic peptid,

Secondary end points:

Safety of D-vitamin supplementation, well being score, blood pressure, BMI Walking distant in 6 minutes

Visits:

Screening, Randomization, 1month, 2 month, 3 month, 6 month, 12 month, 24 month,

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • NYHA II-IV
  • vitamin D level between 10-30 ng/ml
  • ejection fraction by ultrasound < 40 %

排除标准

  • blood calcium > 2,6 mmol/l
  • urinary calcium > 0,1 mmol/body weight kg/die
  • blood phosphorus > 1,45 mmol/l
  • nephrolithiasis in the history
  • GFR < 30 ml/min
  • vitamin D injection in the last 6 month
  • actual 1,25-OH2-D3 vitamin treatment
  • Myocardial infarction or serious coronaria stenosis in the anamnesis uncontrolled atrial fibrillation
  • serious valve disease

研究组 & 干预措施

25-OH-D3 vitamin

Experimental

180 000 IU 25-OH-D3 vitamin oil per os, per month in the 0, 1, 2, 3, and 6 month at the visit. The patient take the drug under medical control

干预措施: Vigantol oil and MCT oil (Drug)

MCT oil

Placebo Comparator

9 ml MCT oil as placebo in the 0,1,2,3,6 month at the visit, under medical contol

干预措施: Vigantol oil and MCT oil (Drug)

结局指标

主要结局

Survival rate

时间窗: 2 years

次要结局

  • serum brain natriuretic peptid level(2 years)
  • well-being score(2 years)
  • D-vitamin supplementation safety(1 year)
  • walking test in 6 minutes(2 years)
  • ejection fraction by ultrasound(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Istvan Takacs

Principal investigator

Semmelweis University

研究点 (2)

Loading locations...

相似试验